ASTALLTD
ASTAL LABORATORIES financials
- Market cap
- ₹345 Cr
Quarterly results
Q1 FY27: revenue up 298.5%, net profit up 350.7% against the same quarter last year.
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 | Q1 FY27 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 13 | 14 | 23 | 25 | 38 +185% | 52 +261% | 134 +471% | 101 +298% |
| EBITDA | 3 | 3 | 4 | 3 | 4 +34% | 4 +7% | 10 +144% | 12 +289% |
| Net profit | 2 | 2 | 3 | 2 | 3 +29% | 2 −5% | 8 +180% | 9 +351% |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Performance −6.4% 1Y
1Y: ₹81.45 on 10 Sept 2025 → ₹76.2. High ₹100.62 (23 Oct 2025), low ₹61.52 (5 May 2026).
Financials, as filed
Revenue grew 169.6% a year over 2 years, FY24 to FY26. Operating margin widened to 8.3%.
| Year ending | FY24 | FY25 | FY26 |
|---|---|---|---|
| Revenue | ₹34 Cr | ₹64 Cr | ₹249 Cr |
| Operating profit | ₹2 Cr | ₹13 Cr | ₹21 Cr |
| Operating margin | 4.8% | 19.9% | 8.3% |
| Interest | ₹0 Cr | ₹1 Cr | ₹2 Cr |
| Depreciation | ₹0 Cr | ₹0 Cr | ₹1 Cr |
| Net profit | ₹2 Cr | ₹9 Cr | ₹15 Cr |
| Net margin | 4.7% | 13.9% | 5.9% |
| Cash from operations | — | ₹-13 Cr | ₹-18 Cr |
| Free cash flow | — | ₹-18 Cr | ₹-19 Cr |
| ROCE | — | — | 9.0% |
How to read this
From the company's own filings. Margins are computed from the filed sums; a year with an incomplete quarter is left blank rather than estimated.
Balance sheet
| Year ending | FY21 | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|---|
| Equity capital | ₹4 Cr | ₹4 Cr | ₹4 Cr | ₹10 Cr | ₹11 Cr | ₹42 Cr |
| Reserves | ₹1 Cr | ₹1 Cr | ₹1 Cr | ₹13 Cr | ₹33 Cr | ₹292 Cr |
| Borrowings | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹13 Cr | ₹50 Cr |
| Other liabilities | ₹0 Cr | ₹0 Cr | ₹5 Cr | ₹13 Cr | ₹44 Cr | ₹135 Cr |
| Total liabilities | ₹5 Cr | ₹5 Cr | ₹10 Cr | ₹37 Cr | ₹101 Cr | ₹518 Cr |
| Fixed assets | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹1 Cr | ₹11 Cr | ₹268 Cr |
| Capital work in progress | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Investments | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
| Other assets | ₹5 Cr | ₹5 Cr | ₹10 Cr | ₹36 Cr | ₹89 Cr | ₹251 Cr |
| Total assets | ₹5 Cr | ₹5 Cr | ₹10 Cr | ₹37 Cr | ₹101 Cr | ₹518 Cr |
How to read this
As filed each year. A line the company does not report — deposits for a non-lender, for instance — is left out rather than shown as a row of dashes.
Who owns it
As disclosed at Jun 2026
Since Jun 2025, promoters trimmed −15.40 pp while the public added +15.38 pp. The shareholder count grew 20% to 3,274.
- Promoters
- 4.5%
- Public
- 95.5%
Since Jun 2025
- Promoters −15.40 pp
- Public +15.38 pp
How it drifted, 12 quarters
Over this window promoters fell from 55.7% to 4.5% — −51.2 pp.
Ownership split by quarter, oldest first. Sep '23: Promoters 55.7%, Public 44.3%.Dec '23: Promoters 39.8%, Public 60.2%.Mar '24: Promoters 19.9%, Public 80.1%.Jun '24: Promoters 19.9%, Public 80.1%.Sep '24: Promoters 19.9%, Public 80.1%.Dec '24: Promoters 19.9%, Public 80.1%.Mar '25: Promoters 19.9%, Public 80.1%.Jun '25: Promoters 19.9%, Public 80.1%.Sep '25: Promoters 18.2%, Public 81.8%.Dec '25: Promoters 18.2%, Public 81.8%.Mar '26: Promoters 4.7%, Public 95.3%.Jun '26: Promoters 4.5%, Public 95.5%.
Who bought this quarter
since Mar 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- Pavani Vupparapalli +0.45 pp 3.77% held
- Kunapareddy Bala Gopala Krishna Rao . +0.18 pp 1.28% held
The same filing shows 11 holders trimming and 0 off the list — both are in the register beside this.
Who is on the register
Named in the Jun 2026 filing
Every holder of ASTAL LABORATORIES LIMITED above SEBI's 1% disclosure line, and what changed since Mar 2026.
| Holder | Stake | Change |
|---|---|---|
| Sesha Sai Nikhil Chintalapati | 11.38% | −0.43 pp |
| Suryanarayana Raju Rudraraju . | 6.75% | −0.25 pp |
| Kommera Harish | 6.43% | −0.24 pp |
| Amit Mishra | 4.57% | −0.17 pp |
| Aceso Research Labs Llp | 4.53% | −0.17 pp |
| Abraham George | 4.40% | −0.10 pp |
| Liju Mathew | 3.81% | −0.14 pp |
| Pavani Vupparapalli | 3.77% | +0.45 pp |
| Venkataramana Reddy Mallela | 2.85% | −0.11 pp |
| Pradeepkumar M G | 2.65% | −0.10 pp |
| Doradla Radha Krishna | 2.57% | −0.10 pp |
| K S Srinivas Rao | 1.90% | −0.07 pp |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Learn to analyse ASTAL LABORATORIES LIMITED
Guides on how to read this kind of business and the numbers that matter.